Arcturus Therapeutics Holdings Inc
ARCT
Market Cap$330.87M
Close$
$-26.42
307.5% downside
Current Fair Value
307.5% downsideOvervalued by 307.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $330.87 Million |
|---|---|
| Enterprise Value | $171.76 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3 |
| Beta | 2.37 |
| Outstanding Shares | 27,107,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.85 |
|---|---|
| PEG | 3.93 |
| Price to Sales | 2.55 |
| Price to Book Ratio | 1.59 |
| Enterprise Value to Revenue | 1.16 |
| Enterprise Value to EBIT | -3.37 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 0.25 |
Revenue Sources
No data
Insider Trades
ESG Score
No data